 |
|
|
|
|
|
 |
Company Information |
|
|
| Title |
 |
Publication Date |
 |
Price |
|
|
|
|
EvaluatePharma® Yearbook
Company Performance Tables
|
August 2008 |
£1450 |
Premium Company Profile - ViroPharma
Strategy, SWOT Analysis and 5-year Financial Insights with In-depth Company Profile
|
August 2008 |
£265 |
Trinity Health Healthcare - Managed Care and Hospitals SWOT Report
|
July 2008 |
£62 |
Vectura Group plc - Healthcare - Medical Equipment - SWOT Report
|
July 2008 |
£62 |
Wellmont Health System Healthcare - Managed Care and Hospitals SWOT Report
|
July 2008 |
£62 |
Advocate Health Care Healthcare - Managed Care and Hospitals SWOT Report
|
July 2008 |
£62 |
Blue Shield Of California Healthcare - Managed Care and Hospitals SWOT Report
|
July 2008 |
£62 |
Blue Cross and Blue Shield of Florida, Inc. Healthcare - Managed Care and Hospitals SWOT Report
|
July 2008 |
£62 |
St. Joseph Health System Healthcare - Managed Care and Hospitals SWOT Report
|
July 2008 |
£62 |
SHEERVISION, INC. - Healthcare - Medical Equipment - SWOT Report
|
July 2008 |
£62 |
Blue Shield of California Healthcare
Managed Care and Hospitals SWOT Report
|
July 2008 |
£62 |
Blue Cross and Blue Shield of Florida, Inc. Healthcare
Managed Care and Hospitals SWOT Report
|
July 2008 |
£62 |
Advocate Health Care Healthcare
Managed Care and Hospitals SWOT Report
|
July 2008 |
£62 |
Lee Memorial Health System Healthcare
Managed Care and Hospitals SWOT Report
|
July 2008 |
£62 |
Sheervision, Inc. Healthcare
Medical Equipment SWOT Report
|
July 2008 |
£62 |
Wellmont Health System Healthcare
Managed Care and Hospitals SWOT Report
|
July 2008 |
£62 |
Trinity Health Healthcare
Managed Care and Hospitals SWOT Report
|
July 2008 |
£62 |
St. Joseph Health System Healthcare
Managed Care and Hospitals SWOT Report
|
July 2008 |
£62 |
Lee Memorial Health System Healthcare - Managed Care and Hospitals SWOT Report
|
July 2008 |
£62 |
Vectura Group Plc Healthcare
Medical Equipment SWOT Report
|
July 2008 |
£62 |
Schering-Plough Corporation
PharmaVitae Profile
|
July 2008 |
£2995 |
Wyeth
PharmaVitae Profile
|
July 2008 |
£2995 |
Bayer Schering Pharma Ag
PharmaVitae Profile
|
July 2008 |
£2995 |
Johnson & Johnson
PharmaVitae Profile
|
July 2008 |
£2995 |
AstraZeneca Plc
PharmaVitae Profile
|
July 2008 |
£2995 |
Nycomed International Management GmbH - SWOT Analysis
|
June 2008 |
£63 |
Sepracor Inc. - SWOT Analysis
|
June 2008 |
£63 |
Menarini Group - SWOT Analysis
|
June 2008 |
£63 |
Sigma-Aldrich Corporation - SWOT Analysis
|
June 2008 |
£63 |
Les Laboratoires Servier - SWOT Analysis
|
June 2008 |
£63 |
UCB Group - SWOT Analysis
|
June 2008 |
£63 |
UnitedHealth Group Inc. - SWOT Analysis
|
June 2008 |
£63 |
Chemtura Corporation - SWOT Analysis
|
June 2008 |
£63 |
Novo Nordisk A/S - SWOT Analysis
|
June 2008 |
£63 |
Allergan, Inc. - SWOT Analysis
|
June 2008 |
£63 |
Boehringer Ingelheim GmbH - SWOT Analysis
|
June 2008 |
£63 |
H Lundbeck A/S - SWOT Analysis
|
June 2008 |
£63 |
Transammonia, Inc. - SWOT Analysis
|
June 2008 |
£63 |
Endo Pharmaceuticals Holdings Inc. - SWOT Analysis
SWOT Analysis
|
June 2008 |
£63 |
Johnson & Johnson - SWOT Analysis
|
June 2008 |
£63 |
Forest Laboratories, Inc - SWOT Analysis
|
June 2008 |
£63 |
Elan Corporation, plc - SWOT Analysis
|
June 2008 |
£63 |
King Pharmaceuticals, Inc - SWOT Analysis
|
June 2008 |
£63 |
W. R. Grace & Co - SWOT Analysis
|
June 2008 |
£63 |
PolyOne Corporation - SWOT Analysis
|
June 2008 |
£63 |
E.ON AG - SWOT Analysis
|
June 2008 |
£63 |
Wyeth - SWOT Analysis
|
June 2008 |
£63 |
CVS Caremark Corporation - SWOT Analysis
|
June 2008 |
£63 |
Bard Medical Device Company Intelligence Report
|
May 2008 |
£295 |
Shire: Pipeline | Products | Performance | Potential
|
May 2008 |
£595 |
DURECT Corporation Product Pipeline Analysis
|
May 2008 |
£380 |
B-Balloon Ltd. Product Pipeline Analysis
|
May 2008 |
£380 |
Covidien Ltd.Tyco Healthcare Product Pipeline Analysis
|
May 2008 |
£380 |
Digene Corporation Product Pipeline Analysis
|
May 2008 |
£380 |
BioSyntech, Inc. Product Pipeline Analysis
|
May 2008 |
£380 |
Bovie Medical Corporation Product Pipeline Analysis
|
May 2008 |
£380 |
GE Healthcare Product Pipeline Analysis
|
May 2008 |
£380 |
Avalon Laboratories, Inc. Product Pipeline Analysis
|
May 2008 |
£380 |
Gamma Medica-Ideas, Inc. Product Pipeline Analysis
|
May 2008 |
£380 |
FlowMedica, Inc. Product Pipeline Analysis
|
May 2008 |
£380 |
FIT Biotech Oyj Plc. Product Pipeline Analysis
|
May 2008 |
£380 |
ES Vascular Ltd. Product Pipeline Analysis
|
May 2008 |
£380 |
Exiqon AS Product Pipeline Analysis
|
May 2008 |
£380 |
ERBLAN Surgical, Inc. Product Pipeline Analysis
|
May 2008 |
£380 |
ALung Technologies, Inc. Product Pipeline Analysis
|
May 2008 |
£380 |
Advanced Bionics Corporation Product Pipeline Analysis
|
May 2008 |
£380 |
Advanced Neuromodulation Systems, Inc. Product Pipeline Analysis
|
May 2008 |
£380 |
ATS Medical, Inc. Product Pipeline Analysis
|
May 2008 |
£380 |
ARKRAY, Inc. Product Pipeline Analysis
|
May 2008 |
£380 |
HandyLab, Inc. Product Pipeline Analysis
|
May 2008 |
£380 |
ABIOMED, Inc. Product Pipeline Analysis
|
May 2008 |
£380 |
Advanced Ocular Systems Limited Product Pipeline Analysis
|
May 2008 |
£380 |
AerovectRx Corporation Product Pipeline Analysis
|
May 2008 |
£380 |
Amedica Corporation Product Pipeline Analysis
|
May 2008 |
£380 |
Aniara Corporation Product Pipeline Analysis
|
May 2008 |
£380 |
Alma Lasers, Ltd. Product Pipeline Analysis
|
May 2008 |
£380 |
Alltracel Pharmaceuticals plc Product Pipeline Analysis
|
May 2008 |
£380 |
Allergan, Inc. Product Pipeline Analysis
|
May 2008 |
£380 |
Atrium Medical Corporation Product Pipeline Analysis
|
May 2008 |
£380 |
DiaSorin S.p.A Product Pipeline Analysis
|
May 2008 |
£380 |
Victhom Human Bionics Inc. Product Pipeline Analysis
|
May 2008 |
£380 |
Vivoxid Ltd. Product Pipeline Analysis
|
May 2008 |
£380 |
Viacor, Inc. Product Pipeline Analysis
|
May 2008 |
£380 |
Ventracor Limited Product Pipeline Analysis
|
May 2008 |
£380 |
Vectura Group plc Product Pipeline Analysis
|
May 2008 |
£380 |
Volcano Corporation Product Pipeline Analysis
|
May 2008 |
£380 |
W. L. Gore & Associates, Inc. Product Pipeline Analysis
|
May 2008 |
£380 |
B·R·A·H·M·S Aktiengesellschaft Product Pipeline Analysis
|
May 2008 |
£380 |
Immunicon Corporation Product Pipeline Analysis
|
May 2008 |
£380 |
bioMerieux S.A. Product Pipeline Analysis
|
May 2008 |
£380 |
Ziosoft Incorporated Product Pipeline Analysis
|
May 2008 |
£380 |
World Heart Corporation Product Pipeline Analysis
|
May 2008 |
£380 |
Sutura, Inc. Product Pipeline Analysis
|
May 2008 |
£380 |
Vascular Solutions, Inc. Product Pipeline Analysis
|
May 2008 |
£380 |
NIR Diagnostics Inc. Product Pipeline Analysis
|
May 2008 |
£380 |
SpectRx, Inc. Product Pipeline Analysis
|
May 2008 |
£380 |
Myocor Inc. Product Pipeline Analysis
|
May 2008 |
£380 |
LiDCO Group Plc Product Pipeline Analysis
|
May 2008 |
£380 |
Irvine Biomedical, Inc. Product Pipeline Analysis
|
May 2008 |
£380 |
K2M, Inc. Product Pipeline Analysis
|
May 2008 |
£380 |
OMRON HEALTHCARE Co., Ltd. Product Pipeline Analysis
|
May 2008 |
£380 |
NanoSpine Corporation Product Pipeline Analysis
|
May 2008 |
£380 |
Shelhigh, Inc. Product Pipeline Analysis
|
May 2008 |
£380 |
Orthofix International N.V. Product Pipeline Analysis
|
May 2008 |
£380 |
Saliva Diagnostic Systems, Inc. Product Pipeline Analysis
|
May 2008 |
£380 |
Osteotech, Inc. Product Pipeline Analysis
|
May 2008 |
£380 |
Pindi Products, Inc. Product Pipeline Analysis
|
May 2008 |
£380 |
Bristol-Myers Squibb Company - SWOT Analysis
|
May 2008 |
£63 |
Merck & Co., Inc. - SWOT Analysis
SWOT Analysis
|
May 2008 |
£63 |
C. R. Bard, Inc. - SWOT Analysis
|
May 2008 |
£63 |
St. Jude Medical, Inc. - SWOT Analysis
|
May 2008 |
£63 |
Celesio AG - SWOT Analysis
|
May 2008 |
£63 |
ImClone Systems Incorporated - SWOT Analysis
|
May 2008 |
£63 |
aaiPharma Inc - SWOT Analysis
|
May 2008 |
£63 |
ISTA Pharmaceuticals, Inc. - SWOT Analysis
SWOT Analysis
|
May 2008 |
£63 |
Abbott Laboratories - SWOT Analysis
|
May 2008 |
£63 |
Larka CMO Companies Listing
Online Directory
|
May 2008 |
£550 |
Danaher Corporation
Premium Company Profile
|
April 2008 |
£265 |
Cytori Therapeutics Inc
Premium Company Profile
|
April 2008 |
£265 |
La Jolla Pharmaceutical Co
Premium Company Profile
|
April 2008 |
£265 |
Lev Pharmaceuticals Inc
Premium Company Profile
|
April 2008 |
£265 |
Illumina Inc
Premium Company Profile
|
April 2008 |
£265 |
Incyte Corporation
Premium Company Profile
|
April 2008 |
£265 |
Javelin Pharmaceuticals Inc
Premium Company Profile
|
April 2008 |
£265 |
Csl Limited
Premium Company Profile
|
April 2008 |
£265 |
Introgen Therapeutics Inc
Premium Company Profile
|
April 2008 |
£265 |
Kv Pharmaceutical Company
Premium Company Profile
|
April 2008 |
£265 |
Carl Zeiss Meditec Ag
Premium Company Profile
|
April 2008 |
£265 |
Avigen Inc
Premium Company Profile
|
April 2008 |
£265 |
Antisoma plc
Premium Company Profile
|
April 2008 |
£265 |
Anesiva Inc
Premium Company Profile
|
April 2008 |
£265 |
Allos Therapeutics Inc
Premium Company Profile
|
April 2008 |
£265 |
Beckman Coulter Inc
Premium Company Profile
|
April 2008 |
£265 |
Becton, Dickinson and Co
Premium Company Profile
|
April 2008 |
£265 |
C.R. Bard Inc
Premium Company Profile
|
April 2008 |
£265 |
Boston Scientific Corporation
Premium Company Profile
|
April 2008 |
£265 |
Bioms Medical Corp
Premium Company Profile
|
April 2008 |
£265 |
Cougar Biotechnology Inc
Premium Company Profile
|
April 2008 |
£265 |
Optimer Pharmaceuticals Inc
Premium Company Profile
|
April 2008 |
£265 |
Stryker Corporation
Premium Company Profile
|
April 2008 |
£265 |
St. Jude Medical Inc
Premium Company Profile
|
April 2008 |
£265 |
Varian Medical Systems Inc
Premium Company Profile
|
April 2008 |
£265 |
Zimmer Holdings Inc
Premium Company Profile
|
April 2008 |
£265 |
Lexicon Pharmaceuticals Inc
Premium Company Profile
|
April 2008 |
£265 |
Transition Therapeutics Inc
Premium Company Profile
|
April 2008 |
£265 |
TorreyPines Therapeutics Inc
Premium Company Profile
|
April 2008 |
£265 |
Theratechnologies Inc
Premium Company Profile
|
April 2008 |
£265 |
Smith & Nephew plc
Premium Company Profile
|
April 2008 |
£265 |
Spectrum Pharmaceuticals Inc
Premium Company Profile
|
April 2008 |
£265 |
Poniard Pharmaceuticals Inc
Premium Company Profile
|
April 2008 |
£265 |
LifeCell Corporation
Premium Company Profile
|
April 2008 |
£265 |
Micromet Inc
Premium Company Profile
|
April 2008 |
£265 |
MorphoSys Ag
Premium Company Profile
|
April 2008 |
£265 |
MannKind Corporation
Premium Company Profile
|
April 2008 |
£265 |
Panacos Pharmaceuticals Inc
Premium Company Profile
|
April 2008 |
£265 |
Nuvelo Inc
Premium Company Profile
|
April 2008 |
£265 |
Novacea Inc
Premium Company Profile
|
April 2008 |
£265 |
Medtronic Inc
Premium Company Profile
|
April 2008 |
£265 |
Cadinal Health Medical Device Company Intelligence Report
|
April 2008 |
£395 |
Hillenbrand Medical Device Company Intelligence Report
|
April 2008 |
£395 |
Amgen Inc. - SWOT Analysis
SWOT Analysis
|
April 2008 |
£63 |
Cardinal Health, Inc. - SWOT Analysis
SWOT Analysis
|
April 2008 |
£63 |
Nastech Pharmaceutical Company Inc - SWOT Analysis
SWOT Analysis
|
April 2008 |
£63 |
Cytogen Corporation - SWOT Analysis
SWOT Analysis
|
April 2008 |
£63 |
Santarus, Inc. - SWOT Analysis
SWOT Analysis
|
April 2008 |
£63 |
Biogen Idec, Inc.
SWOT Analysis
|
April 2008 |
£63 |
Shire plc - SWOT Analysis
SWOT Analysis
|
April 2008 |
£63 |
Pfizer Inc
SWOT Analysis
|
April 2008 |
£63 |
CollaGenex Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis
|
April 2008 |
£63 |
Introduction of 101 China-based CROs/CMOs serving Western Pharmaceutical and Biotechnology Industry
|
April 2008 |
£455 |
Par Pharmaceutical Generics Company Intelligence Report
Company Intelligence Report
|
March 2008 |
£195 |
Abbott Laboratories
Pipeline,Products,Performance,Potential
|
March 2008 |
£595 |
Alcon
Pipeline,Products,Performance,Potential
|
March 2008 |
£595 |
Watson Pharmaceuticals Generics Company Intelligence Report
Company Intelligence Report
|
March 2008 |
£195 |
Chugai
Pipeline Products Performance Potential
|
March 2008 |
£595 |
Ranbaxy Generics Company Intelligence Report
Company Intelligence Report
|
March 2008 |
£195 |
Hospira Generics Company Intelligence Report
Company Intelligence Report
|
March 2008 |
£195 |
Sawai Pharmaceuticals Generics Company Intelligence Report
Company Intelligence Report
|
March 2008 |
£195 |
Biogen Idec
Pipeline Products Performance Potential
|
March 2008 |
£595 |
Teva Generics Company Intelligence Report
Company Intelligence Report
|
March 2008 |
£195 |
Stada Arzneimittel Generics Company Intelligence Report
Company Intelligence Report
|
March 2008 |
£195 |
Sandoz Generics Company Intelligence Report
Company Intelligence Report
|
March 2008 |
£195 |
Cipla Generics Company Intelligence Report
Company Intelligence Report
|
March 2008 |
£195 |
Zydus Cadila Generics Company Intelligence Report
Company Intelligence Report
|
March 2008 |
£195 |
KRKA Generics Company Intelligence Report
Company Intelligence Report
|
March 2008 |
£195 |
Zentiva Generics Company Intelligence Report
Company Intelligence Report
|
March 2008 |
£195 |
Egis Generics Company Intelligence Report
Company Intelligence Report
|
March 2008 |
£195 |
Ratiopharm Generics Company Intelligence Report
Company Intelligence Report
|
March 2008 |
£195 |
Pliva Generics Company Intelligence Report
Company Intelligence Report
|
March 2008 |
£195 |
Actavis Generics Company Intelligence Report
Company Intelligence Report
|
March 2008 |
£195 |
Wockhardt Generics Company Intelligence Report
Company Intelligence Report
|
March 2008 |
£195 |
Lannett Generics Company Intelligence Report
Company Intelligence Report
|
March 2008 |
£195 |
Aspen Pharmacare Generics Company Intelligence Report
Company Intelligence Report
|
March 2008 |
£195 |
Perrigo Generics Company Intelligence Report
Company Intelligence Report
|
March 2008 |
£195 |
Apotex Generics Company Intelligence Report
Company Intelligence Report
|
March 2008 |
£195 |
Mylan Generics Company Intelligence Report
Company Intelligence Report
|
March 2008 |
£195 |
Gedeon Richter Generics Company Intelligence Report
Company Intelligence Report
|
March 2008 |
£195 |
Dr Reddy Generics Company Intelligence Report
Company Intelligence Report
|
March 2008 |
£195 |
Barr Generics Company Intelligence Report
Company Intelligence Report
|
March 2008 |
£195 |
Bayer Schering Pharma AG - SWOT Analysis
|
March 2008 |
£63 |
Maxygen, Inc. - SWOT Analysis
|
March 2008 |
£63 |
Iasis Healthcare LLC - SWOT Analysis
|
March 2008 |
£63 |
Dyax Corp - SWOT Analysis
|
March 2008 |
£63 |
CollaGenex Pharmaceuticals, Inc. - SWOT Analysis
|
March 2008 |
£63 |
Pfizer Inc - SWOT Analysis
|
March 2008 |
£63 |
Schering-Plough Corporation - SWOT Analysis
|
March 2008 |
£63 |
Hillenbrand Industries, Inc. - SWOT Analysis
|
March 2008 |
£63 |
Progenics Pharmaceuticals Inc - SWOT Analysis
|
March 2008 |
£63 |
Shionogi:
Pipeline • Products • Performance • Potential
|
March 2008 |
£595 |
Bristol-Myers Squibb
Pipeline, Products, Performance, Potential
|
February 2008 |
£595 |
Gilead Sciences
Performance, Products, Pipeline and Potential
|
February 2008 |
£595 |
Ono: Pipeline • Products • Performance • Potential
|
February 2008 |
£595 |
Allergan: Pipeline , Products , Performance , Potential
|
February 2008 |
£595 |
Novartis
Pipeline Products Performance Potential
|
February 2008 |
£595 |
Astellas Pharma
Performance, Products, Pipeline and Potential
|
February 2008 |
£595 |
Takeda
Pipeline, Products,Performance,Potential
|
February 2008 |
£595 |
GlaxoSmithKline Prospects to 2010
Pipeline, Products,Performance,Potential
|
February 2008 |
£595 |
Sinochem - SWOT Analysis
|
February 2008 |
£63 |
BioMarin Pharmaceutical Inc - SWOT Analysis
|
February 2008 |
£63 |
Roche Holding Ltd - SWOT Analysis
|
February 2008 |
£63 |
Bayer AG - SWOT Analysis
|
February 2008 |
£63 |
BUPA - SWOT Analysis
|
February 2008 |
£63 |
DSM N.V. - SWOT Analysis
|
February 2008 |
£63 |
Schwarz Pharma AG - SWOT Analysis
|
February 2008 |
£63 |
Luxottica Group S.p.A. - SWOT Analysis
|
February 2008 |
£63 |
Schering AG - SWOT Analysis
|
February 2008 |
£63 |
Protherics PLC - SWOT Analysis
|
February 2008 |
£63 |
Nobel Biocare Holding AG - SWOT Analysis
|
February 2008 |
£63 |
Merck KGaA - SWOT Analysis
|
February 2008 |
£63 |
Siemens Medical Solutions - SWOT Analysis
|
February 2008 |
£63 |
Hartmann Group - SWOT Analysis
|
February 2008 |
£63 |
OPG Groep - SWOT Analysis
|
February 2008 |
£63 |
Crucell N.V. - SWOT Analysis
|
February 2008 |
£63 |
E.ON - SWOT Analysis
|
February 2008 |
£63 |
Compagnie Generale des Etablissements Michelin - SWOT Analysis
|
February 2008 |
£63 |
Gambro AB - SWOT Analysis
|
February 2008 |
£63 |
Essilor International S.A. - SWOT Analysis
|
February 2008 |
£63 |
Charoen Pokphand Foods Public Company Limited - SWOT Analysis
|
February 2008 |
£63 |
CuraGen Corporation - SWOT Analysis
|
February 2008 |
£63 |
Virbac Corporation - SWOT Analysis
|
February 2008 |
£63 |
Degussa AG - SWOT Analysis
|
February 2008 |
£63 |
Johnson Matthey PLC - SWOT Analysis
|
February 2008 |
£63 |
Edison S.p.A. - SWOT Analysis
|
February 2008 |
£63 |
Philips Medical Systems - SWOT Analysis
|
February 2008 |
£63 |
International Specialty Products Inc - SWOT Analysis
|
February 2008 |
£63 |
Tosoh Corporation - SWOT Analysis
|
February 2008 |
£63 |
Denki Kagaku Kogyo Kabushiki Kaisha - SWOT Analysis
|
February 2008 |
£63 |
Nippon Soda Co., Ltd. - SWOT Analysis
|
February 2008 |
£63 |
First Pacific Company Limited - SWOT Analysis
|
February 2008 |
£63 |
GlaxoSmithKline Plc - SWOT Analysis
|
February 2008 |
£63 |
Linde AG - SWOT Analysis
|
February 2008 |
£63 |
EGIS Pharmaceuticals Plc - SWOT Analysis
|
February 2008 |
£63 |
Shin-Etsu Chemical Co., Ltd. - SWOT Analysis
|
February 2008 |
£63 |
|
|
